Transforming growth factor beta

Transforming growth factor beta
Name	Transforming growth factor beta
Organism	Homo sapiens

Transforming growth factor beta is a multifunctional cytokine family that coordinates cellular processes across development, homeostasis, and disease. Discovered through studies linking oncogenesis, cell proliferation, and wound healing, it has been characterized by biochemical, genetic, and clinical research involving laboratories, universities, and biomedical institutes. Key contributions to understanding its biology have come from collaborations among researchers at institutions such as Harvard University, Stanford University, Massachusetts Institute of Technology, National Institutes of Health, and pharmaceutical companies like Roche and GlaxoSmithKline.

Structure and isoforms

The family comprises multiple isoforms encoded by distinct genes studied in the laboratories of Max Perutz-era structural biology groups and by geneticists associated with Cold Spring Harbor Laboratory and Sanger Institute. Each isoform contains a signal peptide, a latency-associated peptide (LAP), and a mature C-terminal domain whose three-dimensional fold was elucidated by teams at European Molecular Biology Laboratory and Protein Data Bank entries. Crystal structures resolved by groups linked to University of Cambridge and University of Oxford revealed the characteristic cystine-knot motif also found in proteins analyzed by researchers at Yale University and Johns Hopkins University. Isoforms show conserved residues recognized by antibodies developed at Centers for Disease Control and Prevention, and sequence variation cataloged by projects at 1000 Genomes Project and Ensembl explains differential receptor affinity observed in experiments at Cold Spring Harbor Laboratory and Broad Institute.

Signaling pathways

Ligand engagement of type I and type II serine/threonine kinase receptors, characterized in signal-transduction work at Imperial College London and University College London, initiates canonical SMAD-dependent cascades uncovered by investigators affiliated with University of California, San Francisco and University of Pennsylvania. Activated receptor complexes phosphorylate receptor-regulated SMADs that partner with SMAD4, a tumor suppressor analyzed by teams at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, to regulate transcription in cooperation with transcription factors studied at Cold Spring Harbor Laboratory and Max Planck Institute for Biochemistry. Non-canonical pathways engage MAP kinases, PI3K–AKT, and Rho GTPases, pathways mapped by groups at Rockefeller University and Karolinska Institutet, and intersect with pathways modulated by growth factors investigated at Weill Cornell Medicine and University of Toronto.

Biological functions and physiological roles

Transforming growth factor beta family members orchestrate embryogenesis processes explored by developmental biologists at Princeton University and University of California, Berkeley, control epithelial-to-mesenchymal transitions characterized in studies at Columbia University and Yale School of Medicine, and regulate extracellular matrix deposition analyzed in connective tissue research at Mayo Clinic and Cleveland Clinic. They influence immune tolerance and lymphocyte differentiation described in immunology studies at Rockefeller University and University of Oxford, modulate angiogenesis investigated by vascular biology groups at Utrecht University and Karolinska Institutet, and maintain tissue homeostasis in organs studied at Massachusetts General Hospital and Mount Sinai Hospital.

Regulation and activation

Latent complexes sequestered in the extracellular matrix and their activation by integrins, proteases, and mechanical force were elucidated by mechanobiology teams at ETH Zurich and University of Cambridge. Regulatory layers include transcriptional control by factors researched at European Molecular Biology Laboratory and post-translational modification characterized by proteomics groups at EMBL-EBI and ProteomeXchange. MicroRNA-mediated regulation was revealed in collaborative projects involving Wellcome Trust Sanger Institute and McGill University, while epigenetic modulation has been dissected by laboratories at Cold Spring Harbor Laboratory and University of California, San Diego.

Roles in disease and pathology

Dysregulation contributes to fibrosis examined by clinicians at Johns Hopkins Hospital and Cleveland Clinic, to immunopathology studied by investigators at National Institute of Allergy and Infectious Diseases and Karolinska University Hospital, and to cancer progression where its dual tumor-suppressive and pro-metastatic roles were defined in cancer centers such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Its involvement in hereditary disorders and syndromes has been described in genetic clinics at Great Ormond Street Hospital and Sheffield Children's Hospital, while associations with cardiovascular disease were reported by cardiology groups at Johns Hopkins University and Mayo Clinic.

Therapeutic targeting and clinical applications

Therapeutic strategies include neutralizing antibodies developed in industrial research at Genentech and Novartis, receptor kinase inhibitors pursued by teams at Pfizer and AstraZeneca, and ligand traps engineered with biotechnology efforts at Biogen and Amgen. Clinical trials coordinated by consortia involving Food and Drug Administration, European Medicines Agency, and academic medical centers like Massachusetts General Hospital and University College London Hospitals evaluate efficacy in fibrosis, oncology, and autoimmune indications; biomarkers and companion diagnostics have been advanced through partnerships with National Cancer Institute and European Organisation for Research and Treatment of Cancer. Ongoing translational research at Stanford Medicine and UCSF Medical Center aims to refine delivery, safety, and patient selection to improve outcomes in diseases addressed by multidisciplinary teams at Hospitals of the University of Pennsylvania and Brigham and Women's Hospital.

Category:Cytokines